Katrien Pieters

515 total citations
8 papers, 111 citations indexed

About

Katrien Pieters is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Katrien Pieters has authored 8 papers receiving a total of 111 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Immunology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Katrien Pieters's work include Immune Response and Inflammation (2 papers), Immunotherapy and Immune Responses (2 papers) and Renal and related cancers (2 papers). Katrien Pieters is often cited by papers focused on Immune Response and Inflammation (2 papers), Immunotherapy and Immune Responses (2 papers) and Renal and related cancers (2 papers). Katrien Pieters collaborates with scholars based in Sweden, Belgium and Netherlands. Katrien Pieters's co-authors include Urban Gullberg, Andreas Lennartsson, Thomas Hellmark, Mårten Segelmark, Sophie Ohlsson, G Sturfelt, Jörgen Wieslander, Åsa Pettersson, Marc van der Planken and Inge Vrelust and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Journal of Leukocyte Biology.

In The Last Decade

Katrien Pieters

7 papers receiving 108 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katrien Pieters Sweden 5 68 44 41 20 15 8 111
Christian Chatenay‐Rivauday Switzerland 6 24 0.4× 49 1.1× 10 0.2× 5 0.3× 5 0.3× 9 109
Erik Gaitzsch Germany 7 42 0.6× 44 1.0× 4 0.1× 7 0.3× 22 1.5× 8 109
J. D. Aghajanian United States 3 54 0.8× 19 0.4× 10 0.2× 4 0.2× 12 0.8× 5 94
Toshinori Moriguchi Japan 6 45 0.7× 24 0.5× 10 0.2× 2 0.1× 13 0.9× 7 109
Lukas Kalinke United Kingdom 3 90 1.3× 97 2.2× 34 0.8× 3 0.1× 4 0.3× 5 186
Dennis Hoving United Kingdom 2 143 2.1× 64 1.5× 16 0.4× 2 0.1× 4 0.3× 2 171
Pamela Aranda Lopez Germany 8 94 1.4× 20 0.5× 11 0.3× 3 0.1× 9 0.6× 15 131
Sophie Zahalka Austria 5 135 2.0× 35 0.8× 28 0.7× 3 0.1× 1 0.1× 9 186
Reem Mohammed Saudi Arabia 7 85 1.3× 22 0.5× 7 0.2× 1 0.1× 27 1.8× 14 137
Dillon C. Muth United States 7 46 0.7× 143 3.3× 7 0.2× 2 0.1× 4 0.3× 11 194

Countries citing papers authored by Katrien Pieters

Since Specialization
Citations

This map shows the geographic impact of Katrien Pieters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrien Pieters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrien Pieters more than expected).

Fields of papers citing papers by Katrien Pieters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrien Pieters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrien Pieters. The network helps show where Katrien Pieters may publish in the future.

Co-authorship network of co-authors of Katrien Pieters

This figure shows the co-authorship network connecting the top 25 collaborators of Katrien Pieters. A scholar is included among the top collaborators of Katrien Pieters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrien Pieters. Katrien Pieters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Patteet, Lisbeth, Katrien Vermeulen, Katrien Pieters, et al.. (2012). A hypogranular variant of acute promyelocytic leukaemia showing a heterogenic immunophenotype with CD34, CD2, HLA-DR positivity: a case report and review of the literature.. PubMed. 67(1). 34–8. 4 indexed citations
2.
Berneman, Zwi, Ann Van de Velde, Ann Van Driessche, et al.. (2008). Immunogenicity and Antileukemic Activity of Dendritic Cells Electroporated with Wilms’ Tumor WT1 mRNA: A Phase I/II Trial in Acute Myeloid Leukemia. Blood. 112(11). 830–830. 2 indexed citations
3.
Berneman, Zwi, Ann Van Driessche, Ann Van de Velde, et al.. (2007). Vaccination of Acute Myeloid Leukemia Patients with Dendritic Cells Electroporated with mRNA Encoding the Wilms’ Tumor Protein WT1: A Phase I/II Trial.. Blood. 110(11). 158–158. 2 indexed citations
4.
Ohlsson, Sophie, Thomas Hellmark, Katrien Pieters, et al.. (2005). Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis. Clinical & Experimental Immunology. 141(1). 174–182. 31 indexed citations
5.
Lennartsson, Andreas, et al.. (2004). A murine antibacterial ortholog to human bactericidal/permeability-increasing protein (BPI) is expressed in testis, epididymis, and bone marrow. Journal of Leukocyte Biology. 77(3). 369–377. 36 indexed citations
6.
Pieters, Katrien, Åsa Pettersson, Urban Gullberg, & Thomas Hellmark. (2004). The − 564 A/G polymorphism in the promoter region of the proteinase 3 gene associated with Wegener's granulomatosis does not increase the promoter activity. Clinical & Experimental Immunology. 138(2). 266–270. 13 indexed citations
7.
Lennartsson, Andreas, et al.. (2003). AML-1, PU.1, and Sp3 regulate expression of human bactericidal/permeability-increasing protein. Biochemical and Biophysical Research Communications. 311(4). 853–863. 22 indexed citations
8.
Osmark, Peter, et al.. (2003). Heat elution chromatography of immunoglobulins. Protein Expression and Purification. 30(2). 301–303. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026